drug withdrawal
Showing 1 - 25 of >10,000
T-bet B Cells in Persistent Virus Control After Discontinuance
Completed
- Chronic HBV Infection
- Drug Withdrawal
- T-bet B cell
-
Shanghai, ChinaChanghai hospital
Sep 1, 2023
Graves Disease, Relapse, Treatment Trial in Nanjing (Methimazole)
Recruiting
- Graves Disease
- +3 more
-
Nanjing, Chinathe First Affiliated Hospital of Nanjing Medical University
Jul 21, 2022
Drug Withdrawal Symptoms, Critical Care, Child Trial in Oslo (Algorithm for tapering og analgosedation)
Completed
- Drug Withdrawal Symptoms
- +2 more
- Algorithm for tapering og analgosedation
-
Oslo, NorwayOslo University Hospital, Rikshospitalet
Apr 19, 2022
Cardiomyopathy, Dilated Trial (Patients with cardiac function recovered for more than one year and discontinued were in the
Not yet recruiting
- Cardiomyopathy, Dilated
- Patients with cardiac function recovered for more than one year and discontinued were in the discontinuation group.
- (no location specified)
Sep 8, 2023
E-cigarette Use, Withdrawal Trial in Baltimore (Transdermal Nicotine Patch, Placebo Nicotine Patch)
Not yet recruiting
- E-cigarette Use
- Withdrawal
- Transdermal Nicotine Patch
- Placebo Nicotine Patch
-
Baltimore, MarylandBehavioral Pharmacology Research Unit
Sep 28, 2023
Liver Transplant Trial in Boston (biological, procedure, drug)
Recruiting
- Liver Transplant
- arTreg-CSB
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital: Transplantation
Jan 30, 2023
Opioid Withdrawal (Disorder) Trial (Standard of Care with Lofexidine, Standard of Care without Lofexidine)
Not yet recruiting
- Opioid Withdrawal (Disorder)
- Standard of Care with Lofexidine
- Standard of Care without Lofexidine
- (no location specified)
Sep 14, 2023
Neonatal Opioid Withdrawal Syndrome, Neonatal Abstinence Syndrome Trial in Hershey (microRNA-146a level, microRNA-192 level,
Recruiting
- Neonatal Opioid Withdrawal Syndrome
- Neonatal Abstinence Syndrome
- microRNA-146a level
- +2 more
-
Hershey, PennsylvaniaPenn State Milton S. Hershey Medical Center
Jun 30, 2023
Qualitative Understanding of Experiences With the SIMPLIFY Trial
Recruiting
- Cystic Fibrosis
- Drug Withdrawal
- Qualitative Interview
-
Baltimore, Maryland
- +1 more
Mar 26, 2022
Opioid Use Disorder, Opioid Withdrawal Trial (BXCL501 (180 micrograms), BXCL501 (240 micrograms), Placebo)
Not yet recruiting
- Opioid Use Disorder
- Opioid Withdrawal
- BXCL501 (180 micrograms)
- +3 more
- (no location specified)
Jan 24, 2023
Liver Transplant Trial in San Francisco (biological, procedure, drug)
Recruiting
- Liver Transplant
- arTreg
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 13, 2022
Sensorimotor Integration in Monogenic Parkinson-dystonia
Recruiting
- Parkinson
- +5 more
- Transcranial magnetic stimulation (TMS)
- +3 more
-
Lübeck, Schleswig-Holstein, GermanyInstitute of Systems Motor Science Lübeck
Jan 27, 2023
Nicotine Dependence Trial in Baltimore (Transcranial Direct Current Stimulation, Sham)
Suspended
- Nicotine Dependence
- Transcranial Direct Current Stimulation
- sham
-
Baltimore, MarylandNational Institute on Drug Abuse
Jan 4, 2023
Kratom Product Effects Among Regular Consumers
Not yet recruiting
- Withdrawal Symptoms
- Effects from acute kratom exposure
- (no location specified)
Oct 20, 2023
Opioid-Use Disorder Trial in Baltimore (Placebo, TRV734)
Recruiting
- Opioid-Use Disorder
- Placebo
- TRV734
-
Baltimore, MarylandNational Institute on Drug Abuse
Dec 14, 2022
Acute Abstinence From Cigarettes vs E-cigarettes (ENDS) Trial in Buffalo (Acute (24-hour) abstinence, Ad libitum smoking/vaping)
Recruiting
- Acute Abstinence From Cigarettes vs E-cigarettes (ENDS)
- Acute (24-hour) abstinence
- Ad libitum smoking/vaping
-
Buffalo, New YorkUniversity at Buffalo
Mar 6, 2023
Cigarette Smoking, Nicotine Dependence, Nicotine Withdrawal Trial in Tulsa (Smoking Abstinence, Ad Lib Smoking)
Recruiting
- Cigarette Smoking
- +2 more
- Smoking Abstinence
- Ad Lib Smoking
-
Tulsa, OklahomaHardesty Center for Clinical Research and Neuroscience
Jun 10, 2022
Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)
Recruiting
- Chronic Myeloid Leukemia, Chronic Phase
- Withdrawal;Drug
- Imatinib withdrawal
- +2 more
-
Brno, Czechia
- +7 more
Aug 24, 2022
Opioid-use Disorder Trial in Provo (HWBV chair)
Recruiting
- Opioid-use Disorder
- HWBV chair
-
Provo, UtahMigraine and Neuro Rehab Clinic
Oct 4, 2022
Food Addiction Trial in Ann Arbor (Dietary change (low ultra-processed food), Dietary change (high ultra-processed food))
Recruiting
- Food Addiction
- Dietary change (low ultra-processed food)
- Dietary change (high ultra-processed food)
-
Ann Arbor, MichiganUniversity of Michigan
Sep 12, 2023
Opioid Withdrawal, Opioid Use Disorder, Opioid Craving Trial in Baltimore (Morphine, Naloxone + lofexidine pretreatment,
Recruiting
- Opioid Withdrawal
- +2 more
- Morphine
- +3 more
-
Baltimore, MarylandJohns Hopkins University Bayview Medical Campus
Feb 18, 2022
Alagille Syndrome Trial in Worldwide (LUM001 (Maralixibat), Placebo)
Completed
- Alagille Syndrome
- LUM001 (Maralixibat)
- Placebo
-
Westmead, New South Wales, Australia
- +8 more
Jun 23, 2021
Withdrawal Symptoms, Opioid Use Disorder, Opioid Use Trial in Atlanta (Transcutaneous Cervical Vagal Nerve Stimulation, Sham
Not yet recruiting
- Withdrawal Symptoms
- +2 more
- Transcutaneous Cervical Vagal Nerve Stimulation
- +2 more
-
Atlanta, Georgia
- +6 more
Apr 14, 2023
Nicotine Withdrawal, Nicotine Addiction, Drug Effect Trial in Baltimore (Nicotine, Cigarette)
Recruiting
- Nicotine Withdrawal
- +2 more
- Nicotine
- Cigarette
-
Baltimore, MarylandJohns Hopkins Behavioral Pharmacology Research Unit
Dec 7, 2022